PELI Logo
title

References - Low Oxalate Diet Patient Handout

  1. Petroski W, Minich DM. Is there such a thing as "anti-nutrients"? A narrative review of perceived problematic plant compounds. Nutrients. 2020 Sep;12(10):E2929. DOI: 10.3390/nu12102929
  2. Brzica H, Breljak D, Burckhardt BC, Burckhardt G, Sabolić I. Oxalate: from the environment to kidney stones. Arh Hig Rada Toksikol. 2013 Dec;64(4):609-630. DOI: 10.2478/10004-1254-64-2013-2428
  3. Liebman M, Al-Wahsh IA. Probiotics and other key determinants of dietary oxalate absorption. Adv Nutr. 2011 May;2(3):254-260. DOI: 10.3945/an.111.000414
  4. Whittamore JM, Hatch M. The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man. Urolithiasis. 2017 Feb;45(1):89-108. DOI: 10.1007/s00240-016-0952-z
  5. Bhasin B, Ürekli HM, Atta MG. Primary and secondary hyperoxaluria: Understanding the enigma. World J Nephrol. 2015 May;4(2):235-244. DOI: 10.5527/wjn.v4.i2.235
  6. Stauffer JQ. Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Am J Dig Dis. 1977 Oct;22(10):921-928. DOI: 10.1007/BF01076170
  7. Hatch M. Gut microbiota and oxalate homeostasis. Ann Transl Med. 2017 Jan;5(2):36.
  8. Mikami K, Akakura K, Takei K, Ueda T, Mizoguchi K, Noda M, et al. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol. 2003 Jun;10(6):293-296. DOI: 10.1046/j.1442-2042.2003.00634.x
  9. Ermer T, Eckardt KU, Aronson PS, Knauf F. Oxalate, inflammasome, and progression of kidney disease. Curr Opin Nephrol Hypertens. 2016 Jul;25(4):363-371. DOI: 10.1097/MNH.0000000000000229
  10. Asplin JR. The management of patients with enteric hyperoxaluria. Urolithiasis. 2016 Feb;44(1):33-43. DOI: 10.1007/s00240-015-0846-5
  11. Bianchi L, Gaiani F, Bizzarri B, Minelli R, Cortegoso Valdivia P, Leandro G, et al. Renal lithiasis and inflammatory bowel diseases, an update on pediatric population. Acta Biomed. 2018 12;89(9-S):76-80. DOI: 10.23750/abm.v89i9-S.7908
  12. Stauffer JQ. Hyperoxaluria and intestinal disease. The role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Am J Dig Dis. 1977 Oct;22(10):921-928. DOI: 10.1007/BF01076170
  13. Hashimoto S, Yamamoto R, Maoka T, Fukasawa Y, Koike T, Shigematsu T. A case of chronic calcium oxalate nephropathy due to short bowel syndrome and cholecystectomy. Case Rep Nephrol Dial. 2018 May-Aug;8(2):147-154. DOI: 10.1159/000491630
  14. Nightingale JM. Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol. 2003 Dec;17(6):907-929. DOI: 10.1016/s1521-6918(03)00108-2
  15. Suryavanshi MV, Bhute SS, Jadhav SD, Bhatia MS, Gune RP, Shouche YS. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures. Sci Rep. 2016 Oct;6(34712). DOI: 10.1038/srep34712
  16. Jiang J, Knight J, Easter LH, Neiberg R, Holmes RP, Assimos DG. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion. J Urol. 2011 Jul;186(1):135-139. DOI: 10.1016/j.juro.2011.03.006
  17. Saw JJ, Sivaguru M, Wilson EM, Dong Y, Sanford RA, Fields CJ, et al. In vivo entombment of bacteria and fungi during calcium oxalate, brushite, and struvite urolithiasis. Kidney360. 2021 Feb;2(2)298-311. DOI: 10.34067/KID.0006942020
  18. Evan AP. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol. 2010 May;25(5):831-841. DOI: 10.1007/s00467-009-1116-y
  19. Liu Y, Zhao Y, Shukha Y, Lu H, Wang L, Liu Z, et al. Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis. Cell Rep. 2021 Jul;36(4):109420. DOI: 10.1016/j.celrep.2021.109420
  20. Kusumi K, Barr-Beare E, Saxena V, Safedi F, Schwaderer A. Renal calcium oxalate deposits induce a pro-atherosclerotic and pro-osteoporotic response in mice. J Cell Biochem. 2017 Sep;118(9):2744-2751. DOI: 10.1002/jcb.25924
  21. Bacchetta J, Boivin G, Cochat P. Bone impairment in primary hyperoxaluria: a review. Pediatr Nephrol. 2016 Jan;31(1):1-6. DOI: 10.1007/s00467-015-3048-z
  22. Rendina D, De Filippo G, Iannuzzo G, Abate V, Strazzullo P, Falchetti A. Idiopathic osteoporosis and nephrolithiasis: two sides of the same coin. Int J Mol Sci. 2020 Oct;21(21):E8183. DOI: 10.3390/ijms21218183
  23. Patel M, Yarlagadda V, Adedoyin O, Saini V, Assimos DG, Holmes RP, et al. Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line. Redox Biol. 2018 May;15:207-215. DOI: 10.1016/j.redox.2017.12.003
  24. Barr-Beare E, Saxena V, Hilt EE, Thomas-White K, Schober M, Li B, et al. The interaction between Enterobacteriaceae and calcium oxalate deposits. PLoS One. 2015;10(10):e0139575. DOI: 10.1371/journal.pone.0139575
  25. Baggish MS, Sze EH, Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol. 1997 Sep;177(3):507-511. DOI: 10.1016/s0002-9378(97)70137-6
  26. Marickar YMF. Calcium oxalate stone and gout. Urol Res. 2009 Dec;37(6):345-347. DOI: 10.1007/s00240-009-0218-0
  27. Chung HJ, Lin ATL, Lin CC, Chen TJ, Chen KK. Patients with urinary incontinence appear more likely to develop upper urinary tract stones: a nationwide, population-based study with 8-year follow-up. PLoS One. 2016;11(8):e0161223. DOI: 10.1371/journal.pone.0161223
  28. Konstantynowicz J, Porowski T, Zoch-Zwierz W, Wasilewska J, Kadziela-Olech H, Kulak W, et al. A potential pathogenic role of oxalate in autism. Eur J Paediatr Neurol. 2012 Sep;16(5):485-491. DOI: 10.1016/j.ejpn.2011.08.004
  29. Theka T, Rodgers A, Ravenscroft N, Lewandowski S. Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles. Urolithiasis. 2013 Apr;41(2):111-117. DOI: 10.1007/s00240-013-0543-1
  30. Lorenz EC, Michet CJ, Milliner DS, Lieske JC. Update on oxalate crystal disease. Curr Rheumatol Rep. 2013 Jul;15(7):340. DOI: 10.1007/s11926-013-0340-4
  31. Hoffman GS, Schumacher HR, Paul H, Cherian V, Reed R, Ramsay AG, et al. Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann Intern Med. 1982 Jul;97(1):36-42. DOI: 10.7326/0003-4819-97-1-36
  32. Williams J, Holmes RP, Assimos DG, Mitchell T. Monocyte mitochondrial function in calcium oxalate stone formers. Urology. 2016 Jul;93:224.e1-6. DOI: 10.1016/j.urology.2016.03.004
  33. Cordero MD, De Miguel M, Moreno Fernández AM, Carmona López IM, Garrido Maraver J, Cotán D, et al. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: implications in the pathogenesis of the disease. Arthritis Res Ther. 2010;12(1):R17. DOI: 10.1186/ar2918
  34. Bilbao JM, Berry H, Marotta J, Ross RC. Peripheral neuropathy in oxalosis. A case report with electron microscopic observations. Can J Neurol Sci. 1976 Feb;3(1):63-67. DOI: 10.1017/s0317167100026020
  35. Wang X, Bhutani G, Vaughan LE, Enders FT, Haskic Z, Milliner D, et al. Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria. BMC Nephrol. 2020 Apr;21(1):133. DOI: 10.1186/s12882-020-01783-z
  36. Rodman JS, Mahler RJ. Kidney stones as a manifestation of hypercalcemic disorders. Hyperparathyroidism and sarcoidosis. Urol Clin North Am. 2000 May;27(2):275-285. DOI: 10.1016/s0094-0143(05)70257-3
  37. Ghio AJ, Roggli VL, Kennedy TP, Piantadosi CA. Calcium oxalate and iron accumulation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2000 Jun;17(2):140-150.
  38. Mykytiv V, Campoy Garcia F. Anemia in patient with primary hyperoxaluria and bone marrow involvement by oxalate crystals. Hematol Oncol Stem Cell Ther. 2018 Jun;11(2):118-121. DOI: 10.1016/j.hemonc.2017.07.007
  39. Luck AN, Bobst CE, Kaltashov IA, Mason AB. Human serum transferrin: is there a link among autism, high oxalate levels, and iron deficiency anemia. Biochemistry. 2013 Nov;52(46):8333-8341. DOI: 10.1021/bi401190m
  40. Mitchell T, Kumar P, Reddy T, Wood KD, Knight J, Assimos DG, et al. Dietary oxalate and kidney stone formation. Am J Physiol Renal Physiol. 2019 Mar;316(3):F409-F413. DOI: 10.1152/ajprenal.00373.2018
  41. Sivaguru M, Saw JJ, Williams JC, Lieske JC, Krambeck AE, Romero MF, et al. Geobiology reveals how human kidney stones dissolve in vivo. Sci Rep. 2018 Sep;8(1):13731. DOI: 10.1038/s41598-018-31890-9
  42. Han H, Segal AM, Seifter JL, Dwyer JT. Nutritional management of kidney stones (nephrolithiasis). Clin Nutr Res. 2015 Jul;4(3):137-152. DOI: 10.7762/cnr.2015.4.3.137
  43. Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009 Oct;20(10):2253-2259. DOI: 10.1681/ASN.2009030276
  44. National Kidney Foundation [Internet]. New York NY: National Kidney Foundation; Calcium oxalate stones; 2019 [updated 2019 Mar; cited 2022 Jan 24]. Available from: https://www.kidney.org/atoz/content/calcium-oxalate-stone
  45. Alelign T, Petros B. Kidney stone disease: an update on current concepts. Adv Urol. 2018;2018:3068365. DOI: 10.1155/2018/3068365
  46. Manissorn J, Fong-Ngern K, Peerapen P, Thongboonkerd V. Systematic evaluation for effects of urine pH on calcium oxalate crystallization, crystal-cell adhesion and internalization into renal tubular cells. Sci Rep. 2017 May;7(1):1798. DOI: 10.1038/s41598-017-01953-4
  47. Welch AA, Mulligan A, Bingham SA, Khaw KT. Urine pH is an indicator of dietary acid-base load, fruit and vegetables and meat intakes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk population study. Br J Nutr. 2008 Jun;99(6):1335-1343. DOI: 10.1017/S0007114507862350
  48. Yoshida S, Miyake T, Yamamoto S, Furukawa S, Niiya T, Senba H, et al. Relationship between urine pH and abnormal glucose tolerance in a community-based study. J Diabetes Investig. 2018 Jul;9(4):769-775. DOI: 10.1111/jdi.12777
  49. Berend K. Review of the diagnostic evaluation of normal anion gap metabolic acidosis. Kidney Dis (Basel). 2017 Dec;3(4):149-159. DOI: 10.1159/000479279
  50. Pazhayattil GS, Shirali AC. Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis. 2014;7:457-468. DOI: 10.2147/IJNRD.S39747
  51. Gélinas B, Seguin P. Oxalate in grain amaranth. J Agric Food Chem. 2007 Jun;55(12):4789-4794. DOI: 10.1021/jf070384d
  52. Akhtar MS, Israr B, Bhatty N, Ali A. Effect of cooking on soluble and insoluble oxalate contents in selected pakistani vegetables and beans. Int J Food Prop. 2009 Jun;14(1):241-249. DOI: 10.1080/10942910903326056
  53. Chai W, Liebman M. Effect of different cooking methods on vegetable oxalate content. J Agric Food Chem. 2005 Apr;53(8):3027-3030. DOI: 10.1021/jf048128d
  54. Shi L, Arntfield SD, Nickerson M. Changes in levels of phytic acid, lectins and oxalates during soaking and cooking of Canadian pulses. Food Res Int. 2018 May;107:660-668. DOI: 10.1016/j.foodres.2018.02.056
  55. D'Alessandro C, Ferraro PM, Cianchi C, Barsotti M, Gambaro G, Cupisti A. Which diet for calcium stone patients: a real-world approach to preventive care. Nutrients. 2019 May;11(5):E1182. DOI: 10.3390/nu11051182
  56. So R, Song S, Lee JE, Yoon HJ. The association between renal hyperfiltration and the sources of habitual protein intake and dietary acid load in a general population with preserved renal function: the KoGES study. PLoS One. 2016;11(11):e0166495. DOI: 10.1371/journal.pone.0166495
  57. Tracy CR, Best S, Bagrodia A, Poindexter JR, Adams-Huet B, Sakhaee K, et al. Animal protein and the risk of kidney stones: a comparative metabolic study of animal protein sources. J Urol. 2014 Jul;192(1):137-141. DOI: 10.1016/j.juro.2014.01.093
  58. Hechtman, L. Clinical naturopathic medicine. Chatswood; Elsevier; 2012. 1596 p.
  59. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988 Jan;66(1):140-146. DOI: 10.1210/jcem-66-1-140
  60. Baxmann AC, De O G Mendonça C, Heilberg IP. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int. 2003 Mar;63(3):1066-1071. DOI: 10.1046/j.1523-1755.2003.00815.x
  61. Knight J, Madduma-Liyanage K, Mobley JA, Assimos DG, Holmes RP. Ascorbic acid intake and oxalate synthesis. Urolithiasis. 2016 Aug;44(4):289-297. DOI: 10.1007/s00240-016-0868-7
  62. Curhan GC. Dietary calcium, dietary protein, and kidney stone formation. Miner Electrolyte Metab. 1997;23(3-6):261-264.
  63. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993 Mar;328(12):833-838. DOI: 10.1056/NEJM199303253281203
  64. Liebman M, Costa G. Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol. 2000 May;163(5):1565-1569.
  65. Ferraro PM, Mandel EI, Curhan GC, Gambaro G, Taylor EN. Dietary protein and potassium, diet-dependent net acid load, and risk of incident kidney stones. Clin J Am Soc Nephrol. 2016 Oct;11(10):1834-1844. DOI: 10.2215/CJN.01520216
  66. Lee Hamm L, Hering-Smith KS, Nakhoul NL. Acid-base and potassium homeostasis. Semin Nephrol. 2013 May;33(3):257-264. DOI: 10.1016/j.semnephrol.2013.04.006
  67. Alamani BG, Gale JD, Rimer JD. Zinc ions modify calcium oxalate growth by distinct transformation of crystal surface termination Cryst Growth Des. 2021 May;21(6):3375-3383. DOI: 10.1021/acs.cgd.1c00166
  68. Ortiz-Alvarado O, Miyaoka R, Kriedberg C, Leavitt DA, Moeding A, Stessman M, et al. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers. Urology. 2012 Feb;79(2):282-286. DOI: 10.1016/j.urology.2011.08.022
  69. Siener R, Jansen B, Watzer B, Hesse A. Effect of n-3 fatty acid supplementation on urinary risk factors for calcium oxalate stone formation. J Urol. 2011 Feb;185(2):719-724. DOI: 10.1016/j.juro.2010.09.074
  70. Gambaro G, Bordoni A, Hrelia S, Bordin L, Biagi P, Semplicini A, et al. Dietary manipulation of delta-6-desaturase modifies phospholipid arachidonic acid levels and the urinary excretion of calcium and oxalate in the rat: insight in calcium lithogenesis. J Lab Clin Med. 2000 Jan;135(1):89-95. DOI: 10.1016/s0022-2143(00)70025-4
  71. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Vitamin B6 intake and the risk of incident kidney stones. Urolithiasis. 2018 Jun;46(3):265-270. DOI: 10.1007/s00240-017-0999-5
  72. Turnlund JR, Betschart AA, Liebman M, Kretsch MJ, Sauberlich HE. Vitamin B-6 depletion followed by repletion with animal- or plant-source diets and calcium and magnesium metabolism in young women. Am J Clin Nutr. 1992 Nov;56(5):905-910. DOI: 10.1093/ajcn/56.5.905
  73. Elizma Lambert [Internet]. Loganholme QLD: Elizma Lambert; [date unknown]. The oxalate factor in yeast overgrowth and mitochondrial dysfunction [cited 2022 Jan 24]. Available from: https://elizmalambert.com/oxalates-yeast-mitochondrial-dysfunction/
logo

Your one stop destination for education and clinical tools, driven by our purpose to inspire people to live better lives through natural healthcare.

Customer Care or Clinical Support

1300 654 336

or visit www.myintegria.com

© 2025, Integria is a registered trademark of Integria Healthcare (Australia) Pty Ltd

Terms of Use | Privacy | Policies